Physician profile
Jonathan P Dunker
NPI 1144543299
$21,410.27
in general payments reported to CMS, 2019-2025
8 companies · $4,838 in 2025
The $4,838 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,324 · 2020: $4,084 · 2021: $2,525 · 2022: $2,479 · 2023: $3,237 · 2024: $1,924 · 2025: $4,838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,667 · Food and Beverage: $2,332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,666.56 |
| Food and Beverage | $2,332.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $13,433.49 | 2019-2025 | |
| Great Lakes Orthopedics | $3,345.14 | 2019-2022 | |
| True North Surgical INC | $1,657.25 | 2023-2025 | |
| Stryker Corporation | $1,450.25 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,147.12 | 2023 | Avenir |
| Polynovo North America LLC | $233.79 | 2024 | Novosorb Btm |
| Medacta USA, INC. | $124.10 | 2024 | |
| Depuy Synthes Sales INC. | $19.13 | 2023 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Dunker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.